102735-88-6

Basic information

• Product Name: 4-FLUORO-2,6-DINITROTOLUENE
• Synonyms: 4-FLUORO-2,6-DINITROTOLUENE;Benzene, 5-fluoro-2-Methyl-1,3-dinitro-;5-Fluoro-2-Methyl-1,3-dinitro-benzene;2,6-dinitro-4-fluoro-tolurene
• CAS NO: 102735-88-6
• Molecular Formula: C₇H₅FN₂O₄
• Molecular Weight: 200.12
• Mol File: 102735-88-6.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 282.6±35.0 °C(Predicted)
• Appearance: /
• Density: 1.497±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 4-FLUORO-2,6-DINITROTOLUENE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-FLUORO-2,6-DINITROTOLUENE(102735-88-6)
• EPA Substance Registry System: 4-FLUORO-2,6-DINITROTOLUENE(102735-88-6)

Safety Data

• Hazardous Substances Data: 102735-88-6(Hazardous Substances Data)

Usage

Uses

5-Fluoro-2-methyl-1,3-dinitrobenzene is used in preparation of Quinazolinone derivatives useful as TNF-α inhibitors for the treatment of cancer and inflammation.

Upstream product

• 352-32-9 p-fluorotoluene 
• 446-10-6 2-nitro-4-fluorotoluene 

Downstream Products

• 885520-14-9 6-fluoro-4-nitro-1H-indazole 
• 1167055-65-3 C₈H₈FNO₃ 
• 16024-29-6 2,6-dinitro-4-methoxytoluene 
• 168770-44-3 5-fluoro-2-methyl-3-nitroaniline 
• 99684-91-0 4-Chloro-2-hydroxy-6-methoxy-1-nitroso-1,2-dihydro-indol-3-one oxime 
• 102735-89-7 2-chloro-4-methoxy-6-nitrotoluene 
• 93490-31-4 4-chlor-6-methoxyindol 
• 16024-30-9 2-amino-4-methoxy-6-nitrotoluene 
• 1058142-18-9 ethyl 6-fluoro-4[(phenoxycarbonyl)amino]-1H-indazole-1-carboxylate 
• 1389326-41-3 3-(4-amino-6-fluoro-1H-indol-1-yl)-3-(4-chlorophenyl)-2-methylpentan-2-ol 
• 1389326-40-2 tert-butyl 1-(3-(4-chlorophenyl)-2-hydroxy-2-methylpentan-3-yl)-6-fluoro-1H-indol-4-ylcarbamate 
• 1389324-99-5 N-(1-(3-(4-chlorophenyl)-2-hydroxy-2-methylpentan-3-yl)-6-fluoro-1H-indol-4-yl)methanesulfonamide 
• 1389326-39-9 methyl 2-(4-chlorophenyl)-2-(6-fluoro-4-(methylsulfonamido)-1H-indol-1-yl)butanoate 
• 1389326-37-7 methyl 2-(4-amino-6-fluoro-1H-indol-1-yl)-2-(4-chlorophenyl)butanoate 

Relevant articles and documents

Indazole compounds and application thereof to preparation of IDO inhibitors

The invention discloses indazole compounds as shown in a formula (i) or (II) which is described in the specification, and a preparation method thereof, and application of the compounds as IDO inhibitors. The compounds provided by the invention can be used for preventing and/or treating a plurality of diseases, such as Alzheimer's disease, cataract, infections related to cellular immune activation,autoimmune diseases, AIDS, cancers, depression, the metabolic disorder of tryptophan or the like.

QUINAZOLINONE DERIVATIVE, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND APPLICATIONS

Disclosed are a quinazolinone derivative, a preparation method therefor, a pharmaceutical composition, and applications. Provided are a compound represented by formula I, a pharmaceutically acceptable salt, a solvate, a crystal form, a eutectic crystal, a

MINERALOCORTICOID RECEPTOR ANTAGONISTS

Disclosed are the compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, which are useful for treating aldosterone-mediated diseases. The processes for preparing compounds of the Formula (I), the use for the therapy and prophyl